Continual growth of foods-relaetd bioventure firms foreseeable

Published: 2002-10-17 06:58:00

Updated: 2002-10-17 06:58:00

Business sources say that function foods-related bioventure firms play a leading role in the related industry thanks to listing of the Kosdaq market, successful attraction of operational fund and advancement to overseas market, which is in a sharp comparison with a majority of new drugs-oriented ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK